ArticleInternational journal of immunopathology and pharmacology

Identification and development of TP53 mutation-associated Long non-coding RNAs signature for optimized prognosis assessment and treatment selection in hepatocellular carcinoma.

Chenghao Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.